+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioprosthetics Market Size, Share & Trends Analysis Report By Product, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 80 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 5998907

Bioprosthetics Market Growth & Trends

The global bioprosthetics market size is expected to reach USD 7.64 billion by 2030, registering a CAGR of 4.40% from 2025 to 2030. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

Bioprosthetics Market Report Highlights

  • The allograft segment is expected to exhibit growth at a significant CAGR during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia
  • The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 9.6% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction
  • Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments
  • In 2023, Europe dominated the overall bioprosthetics market. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region
  • For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe
  • Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Bioprosthetics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Bioprosthetics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Bioprosthetics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Bioprosthetics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Allograft
4.3.1. Allograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Xenograft
4.4.1. Xenograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Bioprosthetics Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Bioprosthetics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Cardiovascular
5.3.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Plastic Surgery & Wound Healing
5.4.1. Plastic Surgery & Wound Healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million
Chapter 6. Bioprosthetics Market: Regional Estimates & Trend Analysis
6.1. Bioprosthetics Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. LeMaitre Vascular, Inc.
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Braile Biomédica
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Labcor Laboratórios Ltda
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Medtronic
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Rua Life Sciences Plc (Aortech International Plc.)
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. LivaNova PLC (Sorin Group)
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Organogenesis Inc.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Humacyte Global, Inc.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Johnson & Johnson (Ethicon, Inc.)
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Artivion, Inc. (CryoLife, Inc.)
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. Abbott (St. Jude Medical, Inc.)
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
7.4.12. Edwards Lifesciences Corporation.
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/ Strategic Initiatives
7.4.13. JenaValve
7.4.13.1. Participant’s Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global Bioprosthetics Market, By Product, 2018 - 2030 (USD Million)
Table 4. Global Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 5. Global Bioprosthetics Market, By Region, 2018 - 2030 (USD Million)
Table 6. North America Bioprosthetics Market, By Country, 2018 - 2030 (USD Million)
Table 7. North America Bioprosthetics Market, By Product, 2018 - 2030 (USD Million)
Table 8. North America Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 9. U.S. Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 10. U.S. Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 11. Canada Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 12. Canada Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 13. Mexico Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 14. Mexico Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 15. Europe Bioprosthetics Market, by Country, 2018 - 2030 (USD Million)
Table 16. Europe Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 17. Europe Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 18. UK. Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 19. UK Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 20. Germany Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 21. Germany Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 22. France Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 23. France Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 24. Italy Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 25. Italy Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 26. Spain Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 27. Spain Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 28. Denmark Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 29. Denmark Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 30. Sweden Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 31. Sweden Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 32. Norway Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 33. Norway Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 34. Asia Pacific Bioprosthetics Market, by Country, 2018 - 2030 (USD Million)
Table 35. Asia Pacific Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 36. Asia Pacific Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 37. Japan Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 38. Japan Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 39. China Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 40. China Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 41. India Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 42. India Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 43. Australia Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 44. Australia Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 45. Thailand Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 46. Thailand Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 47. South Korea Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 48. South Korea Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 49. Latin America Bioprosthetics Market, by Country, 2018 - 2030 (USD Million)
Table 50. Latin America Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 51. Latin America Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 52. Brazil Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 53. Brazil Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 54. Argentina Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 55. Argentina Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa Bioprosthetics Market, by Country, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 59. South Africa Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 60. South Africa Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 63. UAE Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 64. UAE Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
Table 65. Kuwait Bioprosthetics Market, by Product, 2018 - 2030 (USD Million)
Table 66. Kuwait Bioprosthetics Market, By Application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Bioprosthetics market: outlook
Fig. 9 Bioprosthetics competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 Bioprosthetics market driver impact
Fig. 12 Bioprosthetics market restraint impact
Fig. 13 Porter’s Analysis
Fig. 14 PESTLE Analysis
Fig. 15 Bioprosthetics market: Product movement analysis
Fig. 16 Bioprosthetics market: Product outlook and key takeaways
Fig. 17 Allograft market estimates and forecast, 2018 - 2030
Fig. 18 Xenograft market estimates and forecast, 2018 - 2030
Fig. 19 Bioprosthetics market: Application movement analysis
Fig. 20 Bioprosthetics market: Application outlook and key takeaways
Fig. 21 Cardiovascular market estimates and forecasts, 2018 - 2030
Fig. 22 Plastic surgery & wound healing market estimates and forecasts, 2018 - 2030
Fig. 23 Global bronchoscopes market: Regional movement analysis
Fig. 24 Global bronchoscopes market: Regional outlook and key takeaways
Fig. 25 North America bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Key country dynamics
Fig. 27 U.S. bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Key country dynamics
Fig. 29 Canada bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Key country dynamics
Fig. 31 Mexico bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Europe bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 UK bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 Germany bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 Spain bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Key country dynamics
Fig. 40 France bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 Italy bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 Norway bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Denmark bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 Sweden bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Japan bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 China bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 India bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Australia bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 South Korea bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Thailand bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Latin America bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Brazil bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Argentina bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 MEA bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 South Africa bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Saudi Arabia bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 UAE bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Kuwait bronchoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key company categorization
Fig. 77 Heat map analysis 2024

Companies Mentioned

  • LeMaitre Vascular, Inc.
  • Braile Biomédica
  • Labcor Laboratórios Ltda
  • Medtronic
  • Rua Life Sciences Plc (Aortech International Plc.)
  • LivaNova PLC (Sorin Group)
  • Organogenesis Inc.
  • Humacyte Global, Inc.
  • Johnson & Johnson (Ethicon, Inc.)
  • Artivion, Inc. (CryoLife, Inc.)
  • Abbott (St. Jude Medical, Inc.)
  • Edwards Lifesciences Corporation.
  • JenaValve

Methodology

Loading
LOADING...

Table Information